Home LiteratureArticle Details
PMID: 203546 Published · ppublish English Journal Article

Two E-rosette-forming lymphoid cell lines.

International journal of cancer ·Vol. 21 ·No. 2 ·1978-02-15 ·Pages 166-70

Morikawa S, Tatsumi E, Baba M, Harada T, Yasuhira K

Abstract

Two E-rosette (spontaneous rosette with sheep red blood cells)-forming lymphoid cell lines were established. One (HPB-ALL) was derived from a young male Japanese patient with acute lymphoblastic leukemia (ALL), and the other (HPB-MLT) was from a 62-year-old female Japanese patient with a leukemic T-lymphoid malignancy. Formation of E rosettes, absence of any immunoglobulin determinants, absence of EBNA (Epstein-Barr virus associated nuclear antigen) and very limited stimulating ability in mixed lymphocyte culture, were characteristics mostly identical with those of so far established T-cell-derived lymphoid cell lines, MOLT, CCRF-CEM, CCRF-HS-B2, RPMI-8402 and JM. Only HPB-MLT, however, has been derived from an aged patient with T-lymphoid malignancy.

MeSH Terms
Adolescent Antigens, Viral Cell Line Female Herpesvirus 4, Human/immunology Humans Leukemia/immunology Leukemia, Lymphoid/immunology Lymphocyte Culture Test, Mixed Male Middle Aged Receptors, Antigen, B-Cell Rosette Formation T-Lymphocytes/immunology
Chemicals
Antigens, Viral Receptors, Antigen, B-Cell
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Morikawa S
Tatsumi E
Baba M
Harada T
Yasuhira K
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1978-02-15
Pages
166-70
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]